Australia and Oceania: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Australia and Oceania

The human and animal blood market in Australia and Oceania was finally on the rise to reach $X in 2021, after two years of decline. In general, consumption enjoyed a buoyant expansion. As a result, consumption attained the peak level of $X. From 2019 to 2021, the growth of the market remained at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Australia and Oceania

In value terms, human and animal blood production rose remarkably to $X in 2021 estimated in export price. Overall, production saw a resilient increase. The most prominent rate of growth was recorded in 2018 with an increase of X%. Over the period under review, production reached the peak level at $X in 2019; however, from 2020 to 2021, production remained at a lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Australia and Oceania

In 2021, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported in Australia and Oceania; picking up by X% against 2020. Overall, exports showed a resilient increase. The most prominent rate of growth was recorded in 2013 when exports increased by X% against the previous year. Over the period under review, the exports reached the maximum in 2021 and are likely to see gradual growth in the near future.

In value terms, human and animal blood exports surged to $X in 2021. Over the period under review, exports posted a resilient increase. The growth pace was the most rapid in 2013 when exports increased by X% against the previous year. The level of export peaked in 2021 and is expected to retain growth in years to come.

Exports by Country

Australia represented the major exporter of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Australia and Oceania, with the volume of exports finishing at X tons, which was approx. X% of total exports in 2021. It was distantly followed by New Zealand (X tons), constituting a X% share of total exports.

Australia was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports, with a CAGR of +X% from 2012 to 2021. At the same time, New Zealand (+X%) displayed positive paces of growth. While the share of Australia (+X p.p.) increased significantly in terms of the total exports from 2012-2021, the share of New Zealand (-X p.p.) displayed negative dynamics.

In value terms, Australia ($X) remains the largest human and animal blood supplier in Australia and Oceania, comprising X% of total exports. The second position in the ranking was held by New Zealand ($X), with a X% share of total exports.

In Australia, human and animal blood exports expanded at an average annual rate of +X% over the period from 2012-2021.

Export Prices by Country

In 2021, the export price in Australia and Oceania amounted to $X per ton, which is down by -X% against the previous year. Export price indicated a buoyant expansion from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2020, and then declined sharply in the following year.

Average prices varied noticeably amongst the major exporting countries. In 2021, the country with the highest price was Australia ($X per ton), while New Zealand amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by New Zealand (+X%).

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Australia and Oceania

In 2021, supplies from abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by X% to X tons, rising for the second consecutive year after two years of decline. Total imports indicated a remarkable increase from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2019 indices. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood imports skyrocketed to $X in 2021. Overall, imports enjoyed a resilient increase. As a result, imports attained the peak and are likely to continue growth in the immediate term.

Imports by Country

Australia dominates imports structure, resulting at X tons, which was near X% of total imports in 2021. It was distantly followed by New Zealand (X tons), achieving an X% share of total imports.

Australia was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imports, with a CAGR of +X% from 2012 to 2021. New Zealand (-X%) illustrated a downward trend over the same period. percentage points. New Zealand (-X p.p.) saw their shares reduced.

In value terms, Australia ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Australia and Oceania, comprising X% of total imports. The second position in the ranking was taken by New Zealand ($X), with an X% share of total imports.

In Australia, human and animal blood imports expanded at an average annual rate of +X% over the period from 2012-2021.

Import Prices by Country

The import price in Australia and Oceania stood at $X per ton in 2021, waning by -X% against the previous year. Over the period under review, the import price, however, showed a noticeable increase. The growth pace was the most rapid in 2019 when the import price increased by X% against the previous year. As a result, import price reached the peak level of $X per ton. From 2020 to 2021, the import prices failed to regain momentum.

Average prices varied somewhat amongst the major importing countries. In 2021, the country with the highest price was New Zealand ($X per ton), while Australia stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by New Zealand (+X%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :